On Thursday, July 13, the Centers for Medicare & Medicaid Services (CMS) filed the 2024 Medicare physician fee schedule and Quality Payment Program proposed rule, which includes potential revisions to payment policies under the physician fee schedule, Quality Payment Program and other Part B [...]
The American Academy of Sleep Medicine is teaming up with the California Sleep Society to continue advocating for a change to Blue Shield of California’s current positive airway pressure (PAP) therapy reimbursement policy. The payer recently updated its Medical Management of Obstructive Sleep Apnea [...]
DARIEN, IL - The American Academy of Sleep Medicine has launched the “Act on Actigraphy” campaign highlighting the importance of actigraphy testing for sleep disorders and urging payers to reimburse health care professionals for this evidence-based medical service, which is an essential tool for [...]
The AASM urges physician members to participate in a national study being conducted by the American Medical Association (AMA), and supported by 173 health care organizations including the AASM, to collect representative data on physician practice expenses. The aim of the Physician Practice Information [...]
The AASM joins the American Medical Association (AMA) in strongly supporting the Strengthening Medicare for Patients and Providers Act (H.R. 2474), a bipartisan measure now pending in the 118th Congress, which would provide the crucial link between the Medicare physician payment schedule and the [...]
The AASM has been reaching out to Blue Shield of California leadership over the past two months regarding the payer’s denial of reimbursement for positive airway pressure (PAP) therapy when a device with only one respiratory monitoring belt is used in performing the patient’s [...]
After receiving a letter submitted by the American Medical Association (AMA) and more than 100 medical societies, including the American Academy of Sleep Medicine (AASM), Cigna has announced a delay in implementation of its recently revised modifier 25 policy. Modifier 25 enables reporting of [...]
On May 3, the Drug Enforcement Administration (DEA) published a temporary extension of COVID-19 telemedicine flexibilities for prescription of controlled medications for six months, from May 12, 2023, through Nov. 11, 2023, provided all appropriate conditions are met. The rule also provides for a [...]
On April 5, 2023, the Centers for Medicare & Medicaid Services (CMS) published the Medicare Advantage and Part D final rule. This rule summarizes finalized changes to the Medicare Advantage (Medicare Part C), prescription benefit coverage (Medicare Part D), Medicare Cost Plan, and Programs [...]
Palmetto GBA, a Medicare administrative contractor (MAC) for Medicare jurisdictions J and M, revised the polysomnography Local Coverage Determination (LCD) L36593 and its accompanying Local Coverage Article A56995 effective March 16, 2023, to update documentation and billing requirements. These jurisdictions include Alabama, Georgia, Tennessee, [...]